CRISPERassociated Nucleases Market
CRISPER-associated Nucleases Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
2031
Request Sample Report
CRISPER-associated Nucleases Market Size and Growth
The CRISPR-associated nucleases market is experiencing significant growth, driven by advancements in genetic engineering and biotechnology applications. Estimated at approximately $1.5 billion in 2023, the market is projected to expand due to rising investments in research and the increasing adoption of CRISPR technology across various industries, particularly healthcare and agriculture.
Companies Covered
(Covid 19 Impact Covered)
◍ The Odin
◍ Origene
◍ Amsbio
◍ Thermo Fisher Scientific
◍ Merck
◍ Boai Nky Medical Holdings Ltd
◍ Biocompare
◍ BioLabs, Inc.
◍ Inscripta
◍ Sherlock Biosciences
◍ Editas
The CRISPR-associated nucleases market is competitive, with companies like The Odin, Origene, and Thermo Fisher Scientific driving innovation in research and therapeutic applications. They provide essential tools and services that enhance gene editing capabilities. Sales figures reflect this growth, with major players reporting substantial revenues from CRISPR-related products.
Request Sample Report
Market Segmentation
By Application
DNA Editing
RNA Editing
Request Sample Report
By
Product
CRISPER-associated Protein 9 (Cas 9)
Cpf 1
CRISPER-associated Protein 13 (Cas 13)
Market Growth
Request Sample Report
$ X Billion USD
